De-escalation of biological therapy in Inflammatory bowel disease (IBD) and outcomes at week 52: a single centre experience

被引：0
|
作者：
Al-Talib, Ismaeel [1 ]
Iqbal, Majid [1 ]
Shaheen, Sirah [1 ]
Shingadia, Maya [1 ]
Slater, Jayne [1 ]
King, Dominic [1 ]
Rattehalli, Deepa [1 ]
De Silva, Shanika [1 ]
机构：
[1] Dudley Grp NHS Fdn Trust, Dudley, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.132
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P60
引用
收藏
页码：A79 / A79
页数：1
相关论文
共 50 条
  • [31] Thromboembolism in paediatric inflammatory bowel disease- A single centre experience
    Cheah, E.
    Fam, W.
    Lee, C.
    Magoffin, A.
    Dutt, S.
    Stormon, M.
    Gaskin, K.
    O'Loughlin, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 192 - 192
  • [32] Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience
    Madanchi, Mehdi
    Zeitz, Jonas
    Barthel, Christiane
    Samaras, Panagiotis
    Scharl, Sylvie
    Sulz, Michael C.
    Biedermann, Luc
    Frei, Pascal
    Vavricka, Stephan R.
    Rogler, Gerhard
    Scharl, Michael
    DIGESTION, 2016, 94 (01) : 1 - 8
  • [33] The use of sirolimus for refractory inflammatory bowel disease: A single centre experience
    Mutalib, M.
    Blackstock, S.
    Chadokufa, S.
    Huggett, B.
    Shah, N.
    Elawad, M.
    Kiparissi, F.
    Lindley, K.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S195 - S195
  • [34] Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission
    Amiot, Aurelien
    Hulin, Anne
    Belhassan, Mehdi
    Andre, Chantal
    Gagniere, Charlotte
    Le Baleur, Yann
    Farcet, Jean-Pierre
    Delchier, Jean-Charles
    Huee, Sophie
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (01) : 90 - 98
  • [35] Prognosis of patients with inflammatory bowel disease in clinical remission after de-escalation of infliximab maintenance therapy from 8 to 12 weeks
    Vazquez-Moron, J. M.
    Benitez-Rodriguez, B.
    Pallares-Manrique, H.
    Ramos-Lora, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S254 - S254
  • [36] Biologic therapy is safe and effective in inflammatory bowel disease (IBD) patients with previous cancer. Experience of a single tertiary IBD center
    Bar-Yishay, I.
    Ron, Y.
    Santo, E.
    Dotan, I.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S400 - S401
  • [37] Assessment of predictors of the need for biologic therapy in patients with inflammatory bowel disease: a single tertiary centre experience
    Raimundo Fernandes, S.
    Correia, L.
    Santos, P. Moura
    Rita Goncalves, A.
    Valente, A.
    Baldaia, C.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S415 - S415
  • [38] Therapy Escalation in Patients With Inflammatory Bowel Disease Following Clostridium difficile Infection Is not Associated With Adverse Clinical Outcomes: An IBD ReMEdY Study
    Lukin, Dana J.
    Lawlor, Garrett
    Hudesman, David P.
    Durbin, Laura
    Feathers, Alexandra
    Passi, Monica
    Cavaliere, Kimberly
    Axelrad, Jordan E.
    Coburn, Elliot
    Loftus, Michelle
    Jen, Henry
    Rosen, Melissa H.
    Malter, Lisa B.
    Swaminath, Arun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S321 - S321
  • [39] AUDIT OF BIOLOGICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE UK IBD REGISTRY
    Shawihdi, Mustafa
    Cummings, Fraser
    Bloom, Stuart
    Bodger, Keith
    GUT, 2019, 68 : A97 - A98
  • [40] PREVALENCE OF FIBROMYALGIA IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS: A SINGLE CENTRE OBSERVATIONAL PROSPECTIVE STUDY
    Tinazzi, Ilaria
    Variola, Angela
    Geccherle, Andrea
    Marchetta, Antonio
    Mcgonagle, Dennis
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 489 - 489
12345